California Retina Consultants

Summary

California Retina Consultants is a medical facility located in Bakersfield, California. This center is recognized for care of Macular Degeneration, Age-Related Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, Retinal Disease and other specialties. California Retina Consultants is involved with conducting 46 clinical trials across 28 conditions. There are 2 research doctors associated with this hospital, such as Dante Pieramici, MD and Bakersfield Site PI.

Top PIs

Clinical Trials running at California Retina Consultants

Age-Related Macular Degeneration

Macular Degeneration

Retinitis Pigmentosa

Diabetic Retinopathy

Diabetic Macular Edema

Choroidal Neovascularization

Retinal Degeneration

Retinal Disease

None

Choroidal neovascularization

PDS Implant with Ranibizumab

for Age-Related Macular Degeneration

This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR40548 (Archway), Phase IIIb Study WR42221 (Velodrome), or completed Week 24 visit in Study WR42221 but were not eligible to be randomized in WR42221.

Recruiting

2 awards

Phase 3

3 criteria

RGX-314 Gene Therapy

for Age-Related Macular Degeneration

This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.

Recruiting

2 awards

Phase 3

2 criteria

4D-150 + EYLEA

for Age-Related Macular Degeneration

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration

Recruiting

2 awards

Phase 3

4 criteria